Use of L-carnitine and glucose for the treatment of cardiovascular diseases

Details for Australian Patent Application No. 2005262050 (hide)

Owner Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.

Inventors Koverech, Aleardo

Agent Pizzeys

Pub. Number AU-B-2005262050

PCT Pub. Number WO2006/005415

Priority RM2004A000346 13.07.04 IT

Filing date 21 June 2005

Wipo publication date 19 January 2006

Acceptance publication date 24 February 2011

International Classifications

A61K 31/205 (2006.01)

A61K 31/221 (2006.01)

A61K 31/7004 (2006.01) - Monosaccharides having only carbon, hydrogen and oxygen atoms

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 9/00 (2006.01) Drugs for disorders of the cardiovascular system

A61P 9/10 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

11 January 2007 PCT application entered the National Phase

  PCT publication WO2006/005415 Priority application(s): WO2006/005415

24 February 2011 Application Accepted

  Published as AU-B-2005262050

23 June 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005262060-Device and method for automatically analysing blood samples

2005262045-W.C. dispenser with perfuming chamber